35 Humanities "UNC Greensboro" Fellowship positions at Center for Drug Evaluation and Research (CDER) in US

FDA Fellowship Safety and Efficacy of the Emerging Therapeutic Secretory IgA

receptor, FCRL3, on human T cells. The goal of this research project is identification of functionally relevant proteins and cytokines that could result in adverse reactions. Learning Objectives: Under

FDA Bioinformatics Fellowship

include their spouse and minor children, reports what is identified as a Significantly Regulated Organization (SRO) or prohibited investment fund financial interest in any amount, or a relationship with an

FDA Near Real Time Surveillance of the Overdose Crisis Fellowship

investment fund financial interest in any amount, or a relationship with an SRO, except for spousal employment with an SRO, and the individual will not voluntarily divest the financial interest or terminate

FDA Fellowship in Optimizing Drug Dosing in Geriatric Populations

include their spouse and minor children, reports what is identified as a Significantly Regulated Organization (SRO) or prohibited investment fund financial interest in any amount, or a relationship with an

FDA Fellowship in Comparative Gaps Analysis in Sickle Cell Disease

Organization (SRO) or prohibited investment fund financial interest in any amount, or a relationship with an SRO, except for spousal employment with an SRO, and the individual will not voluntarily divest

FDA Development of Cell-based Bioassays Postdoctoral Fellowship

Organization (SRO) or prohibited investment fund financial interest in any amount, or a relationship with an SRO, except for spousal employment with an SRO, and the individual will not voluntarily divest

FDA Research Fellowship in Over-the-Counter Spray Drug Product

team to mimic human usage of the spray products and at the same time achieve the actuation consistency by ensuring precise control of important actuation parameters including force limit, position

CDER Fellowship in Natural History for Rare Pediatric Viral Disease

include their spouse and minor children, reports what is identified as a Significantly Regulated Organization (SRO) or prohibited investment fund financial interest in any amount, or a relationship with an

FDA In Vitro and In Vivo Bioequivalence Fellowship

. Specific research may also involve relevant human factors research and human pharmacokinetics (PK) or clinical endpoint studies. Learning Objectives: Under the guidance of the mentor, the participant will

FDA Postdoctoral Fellowship in Using Modeling and Simulations to Support Bioequivalence

investment fund financial interest in any amount, or a relationship with an SRO, except for spousal employment with an SRO, and the individual will not voluntarily divest the financial interest or terminate